aluates Reports

$ 0.0

Global Oral Antifungal Drugs Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-18K13497

Global Oral Antifungal Drugs Market Research Report 2023

BUY CHAPTERS

Global Oral Antifungal Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-18K13497

Report

December 2024

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Scynexis Inc

Sato Pharmaceutical Co., Ltd.

Mycovia

Novartis Pharmaceuticals Corporation

Oral Antifungal Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Oral Antifungal Drugs Market

The global Oral Antifungal Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Oral Antifungal Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Oral Antifungal Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Oral Antifungal Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Antifungal Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Oral Antifungal Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Oral Antifungal Drugs sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Oral Antifungal Drugs Market Report

Report Metric	Details
Report Name	Oral Antifungal Drugs Market
CAGR	5%
Segment by Type	Polyene Antifungal Agents Imidazole Antifungal Agents Triazole Antifungal Agents Others
Segment by Application	Skin Nail Genitals Others
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Mycovia, Novartis Pharmaceuticals Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Oral Antifungal Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Oral Antifungal Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Antifungal Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oral Antifungal Drugs Market report?

Ans: The main players in the Oral Antifungal Drugs Market are Mycovia, Novartis Pharmaceuticals Corporation

What are the Application segmentation covered in the Oral Antifungal Drugs Market report?

Ans: The Applications covered in the Oral Antifungal Drugs Market report are Skin, Nail, Genitals, Others

What are the Type segmentation covered in the Oral Antifungal Drugs Market report?

Ans: The Types covered in the Oral Antifungal Drugs Market report are Polyene Antifungal Agents, Imidazole Antifungal Agents, Triazole Antifungal Agents, Others

1 Study Coverage

1.1 Oral Antifungal Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Oral Antifungal Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Polyene Antifungal Agents

1.2.3 Imidazole Antifungal Agents

1.2.4 Triazole Antifungal Agents

1.2.5 Others

1.3 Market by Application

1.3.1 Global Oral Antifungal Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Skin

1.3.3 Nail

1.3.4 Genitals

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Oral Antifungal Drugs Sales Estimates and Forecasts 2019-2030

2.2 Global Oral Antifungal Drugs Revenue by Region

2.2.1 Global Oral Antifungal Drugs Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Oral Antifungal Drugs Revenue by Region (2019-2024)

2.2.3 Global Oral Antifungal Drugs Revenue by Region (2025-2030)

2.2.4 Global Oral Antifungal Drugs Revenue Market Share by Region (2019-2030)

2.3 Global Oral Antifungal Drugs Sales Estimates and Forecasts 2019-2030

2.4 Global Oral Antifungal Drugs Sales by Region

2.4.1 Global Oral Antifungal Drugs Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Oral Antifungal Drugs Sales by Region (2019-2024)

2.4.3 Global Oral Antifungal Drugs Sales by Region (2025-2030)

2.4.4 Global Oral Antifungal Drugs Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Oral Antifungal Drugs Sales by Manufacturers

3.1.1 Global Oral Antifungal Drugs Sales by Manufacturers (2019-2024)

3.1.2 Global Oral Antifungal Drugs Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Antifungal Drugs in 2023

3.2 Global Oral Antifungal Drugs Revenue by Manufacturers

3.2.1 Global Oral Antifungal Drugs Revenue by Manufacturers (2019-2024)

3.2.2 Global Oral Antifungal Drugs Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Oral Antifungal Drugs Revenue in 2023

3.3 Global Key Players of Oral Antifungal Drugs, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Oral Antifungal Drugs Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Oral Antifungal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Oral Antifungal Drugs, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Oral Antifungal Drugs, Product Offered and Application

3.8 Global Key Manufacturers of Oral Antifungal Drugs, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Oral Antifungal Drugs Sales by Type

4.1.1 Global Oral Antifungal Drugs Historical Sales by Type (2019-2024)

4.1.2 Global Oral Antifungal Drugs Forecasted Sales by Type (2025-2030)

4.1.3 Global Oral Antifungal Drugs Sales Market Share by Type (2019-2030)

4.2 Global Oral Antifungal Drugs Revenue by Type

4.2.1 Global Oral Antifungal Drugs Historical Revenue by Type (2019-2024)

4.2.2 Global Oral Antifungal Drugs Forecasted Revenue by Type (2025-2030)

4.2.3 Global Oral Antifungal Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Oral Antifungal Drugs Price by Type

4.3.1 Global Oral Antifungal Drugs Price by Type (2019-2024)

4.3.2 Global Oral Antifungal Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Oral Antifungal Drugs Sales by Application

5.1.1 Global Oral Antifungal Drugs Historical Sales by Application (2019-2024)

5.1.2 Global Oral Antifungal Drugs Forecasted Sales by Application (2025-2030)

5.1.3 Global Oral Antifungal Drugs Sales Market Share by Application (2019-2030)

5.2 Global Oral Antifungal Drugs Revenue by Application

5.2.1 Global Oral Antifungal Drugs Historical Revenue by Application (2019-2024)

5.2.2 Global Oral Antifungal Drugs Forecasted Revenue by Application (2025-2030)

5.2.3 Global Oral Antifungal Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Oral Antifungal Drugs Price by Application

5.3.1 Global Oral Antifungal Drugs Price by Application (2019-2024)

5.3.2 Global Oral Antifungal Drugs Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Oral Antifungal Drugs Market Size by Type

6.1.1 US & Canada Oral Antifungal Drugs Sales by Type (2019-2030)

6.1.2 US & Canada Oral Antifungal Drugs Revenue by Type (2019-2030)

6.2 US & Canada Oral Antifungal Drugs Market Size by Application

6.2.1 US & Canada Oral Antifungal Drugs Sales by Application (2019-2030)

6.2.2 US & Canada Oral Antifungal Drugs Revenue by Application (2019-2030)

6.3 US & Canada Oral Antifungal Drugs Market Size by Country

6.3.1 US & Canada Oral Antifungal Drugs Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Oral Antifungal Drugs Sales by Country (2019-2030)

6.3.3 US & Canada Oral Antifungal Drugs Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Oral Antifungal Drugs Market Size by Type

7.1.1 Europe Oral Antifungal Drugs Sales by Type (2019-2030)

7.1.2 Europe Oral Antifungal Drugs Revenue by Type (2019-2030)

7.2 Europe Oral Antifungal Drugs Market Size by Application

7.2.1 Europe Oral Antifungal Drugs Sales by Application (2019-2030)

7.2.2 Europe Oral Antifungal Drugs Revenue by Application (2019-2030)

7.3 Europe Oral Antifungal Drugs Market Size by Country

7.3.1 Europe Oral Antifungal Drugs Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Oral Antifungal Drugs Sales by Country (2019-2030)

7.3.3 Europe Oral Antifungal Drugs Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Oral Antifungal Drugs Market Size

8.1.1 China Oral Antifungal Drugs Sales (2019-2030)

8.1.2 China Oral Antifungal Drugs Revenue (2019-2030)

8.2 China Oral Antifungal Drugs Market Size by Application

8.2.1 China Oral Antifungal Drugs Sales by Application (2019-2030)

8.2.2 China Oral Antifungal Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Oral Antifungal Drugs Market Size by Type

9.1.1 Asia Oral Antifungal Drugs Sales by Type (2019-2030)

9.1.2 Asia Oral Antifungal Drugs Revenue by Type (2019-2030)

9.2 Asia Oral Antifungal Drugs Market Size by Application

9.2.1 Asia Oral Antifungal Drugs Sales by Application (2019-2030)

9.2.2 Asia Oral Antifungal Drugs Revenue by Application (2019-2030)

9.3 Asia Oral Antifungal Drugs Sales by Region

9.3.1 Asia Oral Antifungal Drugs Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Oral Antifungal Drugs Revenue by Region (2019-2030)

9.3.3 Asia Oral Antifungal Drugs Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Oral Antifungal Drugs Market Size by Type

10.1.1 Middle East, Africa and Latin America Oral Antifungal Drugs Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Oral Antifungal Drugs Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Oral Antifungal Drugs Market Size by Application

10.2.1 Middle East, Africa and Latin America Oral Antifungal Drugs Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Oral Antifungal Drugs Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Oral Antifungal Drugs Sales by Country

10.3.1 Middle East, Africa and Latin America Oral Antifungal Drugs Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Oral Antifungal Drugs Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Oral Antifungal Drugs Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Scynexis

11.1.1 Scynexis Company Information

11.1.2 Scynexis Overview

11.1.3 Scynexis Oral Antifungal Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Scynexis Oral Antifungal Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Scynexis Recent Developments

11.2 Sato Pharmaceutical Co., Ltd.

11.2.1 Sato Pharmaceutical Co., Ltd. Company Information

11.2.2 Sato Pharmaceutical Co., Ltd. Overview

11.2.3 Sato Pharmaceutical Co., Ltd. Oral Antifungal Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Sato Pharmaceutical Co., Ltd. Oral Antifungal Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Sato Pharmaceutical Co., Ltd. Recent Developments

11.3 Mycovia

11.3.1 Mycovia Company Information

11.3.2 Mycovia Overview

11.3.3 Mycovia Oral Antifungal Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Mycovia Oral Antifungal Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Mycovia Recent Developments

11.4 Novartis Pharmaceuticals Corporation

11.4.1 Novartis Pharmaceuticals Corporation Company Information

11.4.2 Novartis Pharmaceuticals Corporation Overview

11.4.3 Novartis Pharmaceuticals Corporation Oral Antifungal Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Novartis Pharmaceuticals Corporation Oral Antifungal Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Novartis Pharmaceuticals Corporation Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Oral Antifungal Drugs Industry Chain Analysis

12.2 Oral Antifungal Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Oral Antifungal Drugs Production Mode & Process

12.4 Oral Antifungal Drugs Sales and Marketing

12.4.1 Oral Antifungal Drugs Sales Channels

12.4.2 Oral Antifungal Drugs Distributors

12.5 Oral Antifungal Drugs Customers

13 Market Dynamics

13.1 Oral Antifungal Drugs Industry Trends

13.2 Oral Antifungal Drugs Market Drivers

13.3 Oral Antifungal Drugs Market Challenges

13.4 Oral Antifungal Drugs Market Restraints

14 Key Findings in The Global Oral Antifungal Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Scynexis Inc

Sato Pharmaceutical Co., Ltd.

Mycovia

Novartis Pharmaceuticals Corporation

List of Tables

Table 1. Global Oral Antifungal Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Polyene Antifungal Agents

Table 3. Major Manufacturers of Imidazole Antifungal Agents

Table 4. Major Manufacturers of Triazole Antifungal Agents

Table 5. Major Manufacturers of Others

Table 6. Global Oral Antifungal Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Oral Antifungal Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Oral Antifungal Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Oral Antifungal Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global Oral Antifungal Drugs Revenue Market Share by Region (2019-2024)

Table 11. Global Oral Antifungal Drugs Revenue Market Share by Region (2025-2030)

Table 12. Global Oral Antifungal Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 13. Global Oral Antifungal Drugs Sales by Region (2019-2024) & (K Units)

Table 14. Global Oral Antifungal Drugs Sales by Region (2025-2030) & (K Units)

Table 15. Global Oral Antifungal Drugs Sales Market Share by Region (2019-2024)

Table 16. Global Oral Antifungal Drugs Sales Market Share by Region (2025-2030)

Table 17. Global Oral Antifungal Drugs Sales by Manufacturers (2019-2024) & (K Units)

Table 18. Global Oral Antifungal Drugs Sales Share by Manufacturers (2019-2024)

Table 19. Global Oral Antifungal Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 20. Global Oral Antifungal Drugs Revenue Share by Manufacturers (2019-2024)

Table 21. Global Key Players of Oral Antifungal Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 22. Oral Antifungal Drugs Price by Manufacturers 2019-2024 (US$/Unit)

Table 23. Global Oral Antifungal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Oral Antifungal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antifungal Drugs as of 2023)

Table 25. Global Key Manufacturers of Oral Antifungal Drugs, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Oral Antifungal Drugs, Product Offered and Application

Table 27. Global Key Manufacturers of Oral Antifungal Drugs, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Oral Antifungal Drugs Sales by Type (2019-2024) & (K Units)

Table 30. Global Oral Antifungal Drugs Sales by Type (2025-2030) & (K Units)

Table 31. Global Oral Antifungal Drugs Sales Share by Type (2019-2024)

Table 32. Global Oral Antifungal Drugs Sales Share by Type (2025-2030)

Table 33. Global Oral Antifungal Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 34. Global Oral Antifungal Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 35. Global Oral Antifungal Drugs Revenue Share by Type (2019-2024)

Table 36. Global Oral Antifungal Drugs Revenue Share by Type (2025-2030)

Table 37. Oral Antifungal Drugs Price by Type (2019-2024) & (US$/Unit)

Table 38. Global Oral Antifungal Drugs Price Forecast by Type (2025-2030) & (US$/Unit)

Table 39. Global Oral Antifungal Drugs Sales by Application (2019-2024) & (K Units)

Table 40. Global Oral Antifungal Drugs Sales by Application (2025-2030) & (K Units)

Table 41. Global Oral Antifungal Drugs Sales Share by Application (2019-2024)

Table 42. Global Oral Antifungal Drugs Sales Share by Application (2025-2030)

Table 43. Global Oral Antifungal Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 44. Global Oral Antifungal Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 45. Global Oral Antifungal Drugs Revenue Share by Application (2019-2024)

Table 46. Global Oral Antifungal Drugs Revenue Share by Application (2025-2030)

Table 47. Oral Antifungal Drugs Price by Application (2019-2024) & (US$/Unit)

Table 48. Global Oral Antifungal Drugs Price Forecast by Application (2025-2030) & (US$/Unit)

Table 49. US & Canada Oral Antifungal Drugs Sales by Type (2019-2024) & (K Units)

Table 50. US & Canada Oral Antifungal Drugs Sales by Type (2025-2030) & (K Units)

Table 51. US & Canada Oral Antifungal Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 52. US & Canada Oral Antifungal Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 53. US & Canada Oral Antifungal Drugs Sales by Application (2019-2024) & (K Units)

Table 54. US & Canada Oral Antifungal Drugs Sales by Application (2025-2030) & (K Units)

Table 55. US & Canada Oral Antifungal Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 56. US & Canada Oral Antifungal Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 57. US & Canada Oral Antifungal Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 58. US & Canada Oral Antifungal Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 59. US & Canada Oral Antifungal Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 60. US & Canada Oral Antifungal Drugs Sales by Country (2019-2024) & (K Units)

Table 61. US & Canada Oral Antifungal Drugs Sales by Country (2025-2030) & (K Units)

Table 62. Europe Oral Antifungal Drugs Sales by Type (2019-2024) & (K Units)

Table 63. Europe Oral Antifungal Drugs Sales by Type (2025-2030) & (K Units)

Table 64. Europe Oral Antifungal Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 65. Europe Oral Antifungal Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 66. Europe Oral Antifungal Drugs Sales by Application (2019-2024) & (K Units)

Table 67. Europe Oral Antifungal Drugs Sales by Application (2025-2030) & (K Units)

Table 68. Europe Oral Antifungal Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 69. Europe Oral Antifungal Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 70. Europe Oral Antifungal Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 71. Europe Oral Antifungal Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 72. Europe Oral Antifungal Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 73. Europe Oral Antifungal Drugs Sales by Country (2019-2024) & (K Units)

Table 74. Europe Oral Antifungal Drugs Sales by Country (2025-2030) & (K Units)

Table 75. China Oral Antifungal Drugs Sales by Type (2019-2024) & (K Units)

Table 76. China Oral Antifungal Drugs Sales by Type (2025-2030) & (K Units)

Table 77. China Oral Antifungal Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 78. China Oral Antifungal Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 79. China Oral Antifungal Drugs Sales by Application (2019-2024) & (K Units)

Table 80. China Oral Antifungal Drugs Sales by Application (2025-2030) & (K Units)

Table 81. China Oral Antifungal Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 82. China Oral Antifungal Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 83. Asia Oral Antifungal Drugs Sales by Type (2019-2024) & (K Units)

Table 84. Asia Oral Antifungal Drugs Sales by Type (2025-2030) & (K Units)

Table 85. Asia Oral Antifungal Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 86. Asia Oral Antifungal Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 87. Asia Oral Antifungal Drugs Sales by Application (2019-2024) & (K Units)

Table 88. Asia Oral Antifungal Drugs Sales by Application (2025-2030) & (K Units)

Table 89. Asia Oral Antifungal Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 90. Asia Oral Antifungal Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 91. Asia Oral Antifungal Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 92. Asia Oral Antifungal Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 93. Asia Oral Antifungal Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 94. Asia Oral Antifungal Drugs Sales by Region (2019-2024) & (K Units)

Table 95. Asia Oral Antifungal Drugs Sales by Region (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Oral Antifungal Drugs Sales by Type (2019-2024) & (K Units)

Table 97. Middle East, Africa and Latin America Oral Antifungal Drugs Sales by Type (2025-2030) & (K Units)

Table 98. Middle East, Africa and Latin America Oral Antifungal Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America Oral Antifungal Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 100. Middle East, Africa and Latin America Oral Antifungal Drugs Sales by Application (2019-2024) & (K Units)

Table 101. Middle East, Africa and Latin America Oral Antifungal Drugs Sales by Application (2025-2030) & (K Units)

Table 102. Middle East, Africa and Latin America Oral Antifungal Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Oral Antifungal Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America Oral Antifungal Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 105. Middle East, Africa and Latin America Oral Antifungal Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Oral Antifungal Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Oral Antifungal Drugs Sales by Country (2019-2024) & (K Units)

Table 108. Middle East, Africa and Latin America Oral Antifungal Drugs Sales by Country (2025-2030) & (K Units)

Table 109. Scynexis Company Information

Table 110. Scynexis Description and Major Businesses

Table 111. Scynexis Oral Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 112. Scynexis Oral Antifungal Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. Scynexis Recent Developments

Table 114. Sato Pharmaceutical Co., Ltd. Company Information

Table 115. Sato Pharmaceutical Co., Ltd. Description and Major Businesses

Table 116. Sato Pharmaceutical Co., Ltd. Oral Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 117. Sato Pharmaceutical Co., Ltd. Oral Antifungal Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Sato Pharmaceutical Co., Ltd. Recent Developments

Table 119. Mycovia Company Information

Table 120. Mycovia Description and Major Businesses

Table 121. Mycovia Oral Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 122. Mycovia Oral Antifungal Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. Mycovia Recent Developments

Table 124. Novartis Pharmaceuticals Corporation Company Information

Table 125. Novartis Pharmaceuticals Corporation Description and Major Businesses

Table 126. Novartis Pharmaceuticals Corporation Oral Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 127. Novartis Pharmaceuticals Corporation Oral Antifungal Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. Novartis Pharmaceuticals Corporation Recent Developments

Table 129. Key Raw Materials Lists

Table 130. Raw Materials Key Suppliers Lists

Table 131. Oral Antifungal Drugs Distributors List

Table 132. Oral Antifungal Drugs Customers List

Table 133. Oral Antifungal Drugs Market Trends

Table 134. Oral Antifungal Drugs Market Drivers

Table 135. Oral Antifungal Drugs Market Challenges

Table 136. Oral Antifungal Drugs Market Restraints

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

List of Figures

Figure 1. Oral Antifungal Drugs Product Picture

Figure 2. Global Oral Antifungal Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Oral Antifungal Drugs Market Share by Type in 2023 & 2030

Figure 4. Polyene Antifungal Agents Product Picture

Figure 5. Imidazole Antifungal Agents Product Picture

Figure 6. Triazole Antifungal Agents Product Picture

Figure 7. Others Product Picture

Figure 8. Global Oral Antifungal Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Oral Antifungal Drugs Market Share by Application in 2023 & 2030

Figure 10. Skin

Figure 11. Nail

Figure 12. Genitals

Figure 13. Others

Figure 14. Oral Antifungal Drugs Report Years Considered

Figure 15. Global Oral Antifungal Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Oral Antifungal Drugs Revenue 2019-2030 (US$ Million)

Figure 17. Global Oral Antifungal Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 18. Global Oral Antifungal Drugs Revenue Market Share by Region (2019-2030)

Figure 19. Global Oral Antifungal Drugs Sales 2019-2030 ((K Units)

Figure 20. Global Oral Antifungal Drugs Sales Market Share by Region (2019-2030)

Figure 21. US & Canada Oral Antifungal Drugs Sales YoY (2019-2030) & (K Units)

Figure 22. US & Canada Oral Antifungal Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Europe Oral Antifungal Drugs Sales YoY (2019-2030) & (K Units)

Figure 24. Europe Oral Antifungal Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 25. China Oral Antifungal Drugs Sales YoY (2019-2030) & (K Units)

Figure 26. China Oral Antifungal Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Asia (excluding China) Oral Antifungal Drugs Sales YoY (2019-2030) & (K Units)

Figure 28. Asia (excluding China) Oral Antifungal Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Oral Antifungal Drugs Sales YoY (2019-2030) & (K Units)

Figure 30. Middle East, Africa and Latin America Oral Antifungal Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 31. The Oral Antifungal Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. The Top 5 and 10 Largest Manufacturers of Oral Antifungal Drugs in the World: Market Share by Oral Antifungal Drugs Revenue in 2023

Figure 33. Global Oral Antifungal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 34. Global Oral Antifungal Drugs Sales Market Share by Type (2019-2030)

Figure 35. Global Oral Antifungal Drugs Revenue Market Share by Type (2019-2030)

Figure 36. Global Oral Antifungal Drugs Sales Market Share by Application (2019-2030)

Figure 37. Global Oral Antifungal Drugs Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Oral Antifungal Drugs Sales Market Share by Type (2019-2030)

Figure 39. US & Canada Oral Antifungal Drugs Revenue Market Share by Type (2019-2030)

Figure 40. US & Canada Oral Antifungal Drugs Sales Market Share by Application (2019-2030)

Figure 41. US & Canada Oral Antifungal Drugs Revenue Market Share by Application (2019-2030)

Figure 42. US & Canada Oral Antifungal Drugs Revenue Share by Country (2019-2030)

Figure 43. US & Canada Oral Antifungal Drugs Sales Share by Country (2019-2030)

Figure 44. U.S. Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 45. Canada Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 46. Europe Oral Antifungal Drugs Sales Market Share by Type (2019-2030)

Figure 47. Europe Oral Antifungal Drugs Revenue Market Share by Type (2019-2030)

Figure 48. Europe Oral Antifungal Drugs Sales Market Share by Application (2019-2030)

Figure 49. Europe Oral Antifungal Drugs Revenue Market Share by Application (2019-2030)

Figure 50. Europe Oral Antifungal Drugs Revenue Share by Country (2019-2030)

Figure 51. Europe Oral Antifungal Drugs Sales Share by Country (2019-2030)

Figure 52. Germany Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 53. France Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 54. U.K. Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 55. Italy Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 56. Russia Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 57. China Oral Antifungal Drugs Sales Market Share by Type (2019-2030)

Figure 58. China Oral Antifungal Drugs Revenue Market Share by Type (2019-2030)

Figure 59. China Oral Antifungal Drugs Sales Market Share by Application (2019-2030)

Figure 60. China Oral Antifungal Drugs Revenue Market Share by Application (2019-2030)

Figure 61. Asia Oral Antifungal Drugs Sales Market Share by Type (2019-2030)

Figure 62. Asia Oral Antifungal Drugs Revenue Market Share by Type (2019-2030)

Figure 63. Asia Oral Antifungal Drugs Sales Market Share by Application (2019-2030)

Figure 64. Asia Oral Antifungal Drugs Revenue Market Share by Application (2019-2030)

Figure 65. Asia Oral Antifungal Drugs Revenue Share by Region (2019-2030)

Figure 66. Asia Oral Antifungal Drugs Sales Share by Region (2019-2030)

Figure 67. Japan Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 68. South Korea Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 69. China Taiwan Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 70. Southeast Asia Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 71. India Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 72. Middle East, Africa and Latin America Oral Antifungal Drugs Sales Market Share by Type (2019-2030)

Figure 73. Middle East, Africa and Latin America Oral Antifungal Drugs Revenue Market Share by Type (2019-2030)

Figure 74. Middle East, Africa and Latin America Oral Antifungal Drugs Sales Market Share by Application (2019-2030)

Figure 75. Middle East, Africa and Latin America Oral Antifungal Drugs Revenue Market Share by Application (2019-2030)

Figure 76. Middle East, Africa and Latin America Oral Antifungal Drugs Revenue Share by Country (2019-2030)

Figure 77. Middle East, Africa and Latin America Oral Antifungal Drugs Sales Share by Country (2019-2030)

Figure 78. Brazil Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 79. Mexico Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 80. Turkey Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 81. Israel Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 82. GCC Countries Oral Antifungal Drugs Revenue (2019-2030) & (US$ Million)

Figure 83. Oral Antifungal Drugs Value Chain

Figure 84. Oral Antifungal Drugs Production Process

Figure 85. Channels of Distribution

Figure 86. Distributors Profiles

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions